Tumor-intrinsic Ist1 restricts IFNγ responsiveness to drive immune evasion in pancreatic cancer
This study identifies the tumor-intrinsic factor Ist1 as a critical regulator of immune evasion in pancreatic cancer that restricts IFNγ responsiveness by controlling the membrane stability of the IFNγ receptor, thereby revealing a novel therapeutic target for sensitizing tumors to CD8+ T-cell killing.